Literature DB >> 27817050

Ethylene-vinyl alcohol copolymer as embolic agent for treatment of type II endoleak: our experience.

Anna Maria Ierardi1, Camilla Micieli1, Salvatore Alessio Angileri2, Nicola Rivolta3, Gabriele Piffaretti3, Massimo Tonolini4, Federico Fontana1, Vittorio Miele5, Luca Brunese6, Gianpaolo Carrafiello7.   

Abstract

AIM: To evaluate safety, technical and clinical success of embolization of type II endoleak (T2 EL) using ethylene-vinyl alcohol copolymer as embolic agent alone or in combination with others materials.
MATERIALS AND METHODS: From March 2007 to March 2015, 104 patients presented T2 EL during follow-up. A total of 21 patients met the criteria for treatment. T2 EL was treated with TAE (n = 18), DPSI (n = 10) or laparoscopic ligature of the inferior mesenteric artery (n = 1). DPSI was considered in case TAE was unsuccessful (8/18 patients). Ethylene-vinyl alcohol copolymer was used as embolic agent in 12 patients: alone in 5 cases, in association with glue and with glue and thrombin in 3 and 2 cases, respectively, during TAE. Onyx was injected in two cases of embolization performed with DPSI: in one case alone and in the other in combination with thrombin and glue.
RESULTS: Technical success rate was 100%. Immediate clinical success was 91.7%; in one patient CEUS revealed persistent T2 EL, decreased if compared with that before the procedure. Secondary clinical success was 91.7%; until today, in one patient T2EL is persistent, nevertheless, the sac diameter remained stable. No major or minor complications were registered.
CONCLUSIONS: Onyx could be an ideal embolic agent for endovascular and percutaneous embolization of T2 EL.

Entities:  

Keywords:  Embolization; Ethylene-vinyl alcohol copolymer; Onyx; Type II endoleak

Mesh:

Substances:

Year:  2016        PMID: 27817050     DOI: 10.1007/s11547-016-0703-9

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  14 in total

1.  The use of Onyx for embolization of peripheral vascular malformations in pediatric patients.

Authors:  Murat Cantasdemir; Fatih Gulsen; Serdar Solak; Gokce Yalcin Gulsen; Fatih Kantarci; Furuzan Numan
Journal:  Pediatr Surg Int       Date:  2012-01-22       Impact factor: 1.827

2.  Clinical significance of type II endoleak after endovascular repair of abdominal aortic aneurysm.

Authors:  Dmitri V Gelfand; Geoffrey H White; Samuel E Wilson
Journal:  Ann Vasc Surg       Date:  2006-01       Impact factor: 1.466

3.  Onyx, a new liquid embolic material for peripheral interventions: preliminary experience in aneurysm, pseudoaneurysm, and pulmonary arteriovenous malformation embolization.

Authors:  Ritva L Vanninen; I Manninen
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Mar-Apr       Impact factor: 2.740

4.  Experience of direct percutaneous sac injection in type II endoleak using cone beam computed tomography.

Authors:  Yoong-Seok Park; Young Soo Do; Hong Suk Park; Kwang Bo Park; Dong-Ik Kim
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

5.  Ultra-low profile polymer-filled stent graft for abdominal aortic aneurysm treatment: a two-year follow-up.

Authors:  Anna Maria Ierardi; Dimitrios Tsetis; Christos Ioannou; Domenico Laganà; Chiara Floridi; Mario Petrillo; Antonio Pinto; Gabriele Piffaretti; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2015-01-29       Impact factor: 3.469

6.  Onyx (Ethylene-vinyl Alcohol Copolymer) in Peripheral Applications.

Authors:  Marcelo Guimaraes; Mathew Wooster
Journal:  Semin Intervent Radiol       Date:  2011-09       Impact factor: 1.513

7.  Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).

Authors:  F Duffner; R Ritz; A Bornemann; D Freudenstein; H Wiendl; R Siekmann
Journal:  Clin Neuropathol       Date:  2002 Jan-Feb       Impact factor: 1.368

8.  Embolization of spinal cord arteriovenous malformations with an ethylene vinyl alcohol copolymer dissolved in dimethyl sulfoxide (Onyx liquid embolic system). Report of two cases.

Authors:  A J Molyneux; S C Coley
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

Review 9.  Endoleaks after endovascular repair of abdominal aortic aneurysms.

Authors:  Richard A Baum; S William Stavropoulos; Ronald M Fairman; Jeffrey P Carpenter
Journal:  J Vasc Interv Radiol       Date:  2003-09       Impact factor: 3.464

10.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

View more
  3 in total

1.  The role of ethylene-vinyl alcohol copolymer in association with other embolic agents for the percutaneous and endovascular treatment of type Ia endoleak.

Authors:  Anna Maria Ierardi; Marco Franchin; Federico Fontana; Gabriele Piffaretti; Matteo Crippa; Salvatore Alessio Angileri; Alberto Magenta Biasina; Filippo Piacentino; Matteo Tozzi; Antonio Pinto; Gianpaolo Carrafiello
Journal:  Radiol Med       Date:  2018-04-13       Impact factor: 3.469

2.  Transarterial embolization of peripheral high-flow arteriovenous malformation with ethylene vinyl alcohol copolymer (Onyx®): single-center 10-year experience.

Authors:  Francesco Giurazza; Fabio Corvino; Gianluca Cangiano; Errico Cavaglià; Francesco Amodio; Mattia Silvestre; Giuseppe De Magistris; Raffaella Niola
Journal:  Radiol Med       Date:  2018-10-27       Impact factor: 3.469

3.  Transcatheter embolization with Squid, combined with other embolic agents or alone, in different abdominal diseases: a single-center experience in 30 patients.

Authors:  Massimo Venturini; Carolina Lanza; Paolo Marra; Anna Colarieti; Marta Panzeri; Luigi Augello; Simone Gusmini; Marco Salvioni; Francesco De Cobelli; Alessandro Del Maschio
Journal:  CVIR Endovasc       Date:  2019-02-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.